Avidity Partners Management

Latest statistics and disclosures from Avidity Partners Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Avidity Partners Management

Companies in the Avidity Partners Management portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Call Option (XBI) 8.4 $380M NEW 3.0M 125.71
Acceleron Pharma 4.8 $217M +252% 1.3M 172.11
Mirati Therapeutics (MRTX) 4.2 $188M +41% 1.1M 176.91
Arvinas Ord (ARVN) 4.1 $184M +20% 2.2M 82.18
Abbvie (ABBV) 3.9 $174M +8% 1.6M 107.87
Vertex Pharmaceuticals Incorporated (VRTX) 3.7 $168M -2% 926k 181.39
Zentalis Pharmaceuticals (ZNTL) 3.7 $166M +15% 2.5M 66.64
Avantor (AVTR) 2.9 $133M +2% 3.2M 40.90
Biohaven Pharmaceutical Holding (BHVN) 2.9 $130M +5% 934k 138.91
Syndax Pharmaceuticals (SNDX) 2.0 $92M +4% 4.8M 19.11
Regeneron Pharmaceuticals (REGN) 2.0 $92M NEW 152k 605.18
Seagen (SGEN) 2.0 $91M -16% 537k 169.80
Horizon Therapeutics Pub L SHS (HZNP) 2.0 $91M +45% 826k 109.54
Blueprint Medicines (BPMC) 1.9 $86M +47% 832k 102.81
Astrazeneca Sponsored Adr (AZN) 1.9 $85M NEW 1.4M 60.06
Neurocrine Biosciences (NBIX) 1.8 $81M +24% 849k 95.91
Alnylam Pharmaceuticals (ALNY) 1.8 $81M +118% 427k 188.81
Eli Lilly & Co. (LLY) 1.7 $76M -41% 330k 231.05
Nuvation Bio Com Cl A (NUVB) 1.6 $72M +4% 7.3M 9.94
Natera (NTRA) 1.6 $71M +46% 639k 111.44
Hologic (HOLX) 1.5 $70M -21% 945k 73.81
Baxter International (BAX) 1.5 $69M NEW 862k 80.43
Arena Pharmaceuticals Com New 1.5 $68M +20% 1.1M 59.55
Iveric Bio (ISEE) 1.5 $67M +192% 4.1M 16.24
United Therapeutics Corporation (UTHR) 1.4 $65M +48% 351k 184.58
Stevanato Group S P A Ord Shs (STVN) 1.4 $64M NEW 2.5M 25.31
Sotera Health (SHC) 1.4 $62M +24% 2.4M 26.15
Ideaya Biosciences (IDYA) 1.4 $62M +17% 2.4M 25.49
Caribou Biosciences (CRBU) 1.3 $59M NEW 2.5M 23.87
Catalent (CTLT) 1.2 $53M -26% 398k 133.07
Gritstone Oncology Ord (GRTS) 1.1 $48M +110% 4.5M 10.80
Legend Biotech Corp Sponsored Ads (LEGN) 1.0 $45M +43% 894k 50.56
Ortho Clinical Diagnostics H Ord Shs (OCDX) 1.0 $44M NEW 2.4M 18.48
Pfizer (PFE) 1.0 $44M NEW 1.0M 43.01
Arrowhead Pharmaceuticals (ARWR) 0.9 $42M +547% 674k 62.43
Shattuck Labs (STTK) 0.9 $41M +4% 2.0M 20.38
Ultragenyx Pharmaceutical (RARE) 0.9 $41M NEW 455k 90.19
Immunocore Hldgs Ads (IMCR) 0.9 $41M +82% 1.1M 37.07
Avidity Biosciences Ord (RNA) 0.9 $41M NEW 1.6M 24.63
Iovance Biotherapeutics (IOVA) 0.8 $36M NEW 1.5M 24.66
Insmed Com Par $.01 (INSM) 0.8 $36M +12% 1.3M 27.54
EXACT Sciences Corporation (EXAS) 0.8 $35M -37% 369k 95.45
Compass Pathways Sponsored Ads (CMPS) 0.8 $35M +16% 1.2M 29.87
Alphatec Hldgs Com New (ATEC) 0.8 $34M +6% 2.8M 12.19
Intellia Therapeutics (NTLA) 0.7 $34M -33% 251k 134.15
I Mab Sponsored Ads (IMAB) 0.7 $33M -37% 454k 72.49
Seaspine Holdings (SPNE) 0.7 $31M +27% 1.9M 15.73
Bellus Health Com New (BLU) 0.7 $30M +16% 4.9M 6.14
Kymera Therapeutics (KYMR) 0.7 $30M NEW 515k 58.74
Cyteir Therapeutics (CYT) 0.7 $30M -6% 1.7M 17.55
Altimmune Com New (ALT) 0.5 $25M NEW 2.2M 11.31
Vir Biotechnology (VIR) 0.5 $22M +217% 515k 43.52
Alpine Immune Sciences (ALPN) 0.5 $21M +29% 1.9M 10.67
Essa Pharma Com New (EPIX) 0.4 $20M -10% 2.5M 8.00
Adicet Bio (ACET) 0.4 $19M +7% 2.4M 7.84
Century Therapeutics (IPSC) 0.4 $19M -26% 739k 25.16
Si-bone (SIBN) 0.4 $18M +44% 831k 21.42
Sana Biotechnology (SANA) 0.4 $17M 775k 22.52
Uipath Cl A (PATH) 0.4 $17M +6% 319k 52.61
Field Trip Health Ord (FTRP) 0.4 $16M NEW 3.6M 4.59
Lifestance Health Group (LFST) 0.3 $15M -9% 1.0M 14.50
Phasebio Pharmaceuticals (PHAS) 0.3 $14M +2% 4.4M 3.11
Sema4 Holdings Corp Com Cl A (SMFR) 0.3 $13M NEW 1.7M 7.59
Gh Research Ordinary Shares (GHRS) 0.3 $12M 560k 22.06
Graphite Bio (GRPH) 0.3 $12M 749k 16.39
Ac Immune Sa SHS (ACIU) 0.3 $12M +9% 1.7M 6.71
Scynexis Com New (SCYX) 0.2 $11M 2.1M 5.30
Werewolf Therapeutics (HOWL) 0.2 $11M -3% 625k 17.16
Sentinelone Cl A (S) 0.2 $11M 200k 53.57
Harpoon Therapeutics (HARP) 0.2 $9.4M -20% 1.2M 7.90
Engagesmart Common Stock (ESMT) 0.2 $9.4M NEW 275k 34.06
ACADIA Pharmaceuticals (ACAD) 0.2 $9.1M -41% 550k 16.61
Orchard Therapeutics Ads (ORTX) 0.2 $8.8M 3.8M 2.30
Caremax Com Cl A (CMAX) 0.2 $8.0M 827k 9.66
Zeta Global Holdings Corp Cl A (ZETA) 0.2 $7.6M 1.3M 5.86
Instil Bio (TIL) 0.2 $7.3M +2% 408k 17.88
Monte Rosa Therapeutics (GLUE) 0.1 $6.7M 300k 22.28
Oncosec Medical Incorporated (ONCS) 0.1 $6.3M +5% 2.9M 2.13
Talaris Therapeutics (TALS) 0.1 $6.2M +4% 455k 13.56
Keros Therapeutics (KROS) 0.1 $5.7M NEW 145k 39.56
ZIOPHARM Oncology (TCRT) 0.1 $5.5M NEW 3.0M 1.82
Medicus Sciences Acquisition Cl A Shs (MSAC) 0.1 $5.1M 520k 9.75
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.1 $5.0M 500k 10.05
Bcls Acquisition Corp Com Cl A (BLSA) 0.1 $5.0M 500k 9.96
Dynamics Special Purpose Cor Class A Com (DYNS) 0.1 $5.0M 500k 9.94
Healthcor Catalio Acqu Corp Cl A Shs 0.1 $5.0M 500k 9.90
Panacea Acquisition Corp Ii Cl A Shs (PANA) 0.1 $4.9M 500k 9.77
Somalogic Class A Com (SLGC) 0.1 $4.1M NEW 330k 12.39
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.1 $4.0M 400k 9.89
Helix Acquisition Corp Com Cl A 0.1 $3.9M 400k 9.85
Lifesci Acquisition Ii Corp 0.1 $3.9M 400k 9.80
Tango Therapeutics (TNGX) 0.1 $3.9M NEW 300k 12.93
Zai Lab Adr (ZLAB) 0.1 $3.8M -64% 36k 105.39
Nautilus Biotechnology (NAUT) 0.1 $3.7M -46% 600k 6.14
Sight Sciences (SGHT) 0.1 $3.3M NEW 145k 22.70
Atai Life Sciences Nv SHS (ATAI) 0.1 $3.2M -37% 219k 14.79
Kezar Life Sciences (KZR) 0.0 $2.2M NEW 260k 8.64
Social Cap Suvretta Hlds Crp Class A Ord Shs (DNAA) 0.0 $2.0M 200k 9.95
Social Cap Suvretta Hlds Crp Class A Ord Shs (DNAB) 0.0 $2.0M 200k 9.88
Social Cap Suvretta Hlds Cp Class A Ord Shs (DNAD) 0.0 $2.0M 200k 9.81
Social Cap Suvretta Hld Crpi Class A Ord Shs (DNAC) 0.0 $2.0M 200k 9.80
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) 0.0 $253k 100k 2.53
Somalogic *w Exp 03/01/202 (SLGCW) 0.0 $228k NEW 66k 3.45
Medicus Sciences Acquisition *w Exp 02/12/202 (MSACW) 0.0 $41k 58k 0.71

Past Filings by Avidity Partners Management

SEC 13F filings are viewable for Avidity Partners Management going back to 2019